Investing Insights: Rare Diseases and Market Momentum

This chapter explores investment opportunities in rare disease and oncology companies, spotlighting firms like Scholarock and Meris Pharmaceuticals while discussing the FDA approval landscape. It transitions to market momentum analysis, highlighting historical patterns and upcoming events that could influence stock performance.